FMC (FMC)
(Delayed Data from NYSE)
$62.69 USD
+0.17 (0.27%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $62.70 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$62.69 USD
+0.17 (0.27%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $62.70 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum C VGM
Zacks News
Air Products (APD) Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Air Products' (APD) shares scale new 52-week high on upbeat prospects.
ArcelorMittal to Invest $1 Billion at Mexican Operations
by Zacks Equity Research
ArcelorMittal (MT) will invest $1 billion at its Mexican operations in a three-year investment program, which will improve the quality and efficiency of its operations and optimize asset base.
American Vanguard (AVD) Announces Closure of OHP Acquisition
by Zacks Equity Research
American Vanguard (AVD) completes the acquisition of OHP for an undisclosed price. The buyout will expand its non-crop presence in the market by 50%.
Eastman Chemical (EMN) Inks FDCA Deal With Origin Materials
by Zacks Equity Research
Eastman Chemical (EMN) licenses its FDCA technology to Origin Materials.
Marrone Bio's (MBII) Venerate XC Now Available in New York
by Zacks Equity Research
Marrone Bio (MBII) has announced the availability of Venerate XC bioinsecticide in New York enabling farmers to manage key pests and reduce chemical residues, while reducing the risk of insecticide resistance.
Chemours' (CC) Solid Product Offerings Make it a Must Buy
by Zacks Equity Research
The Chemours Company (CC) is poised to gain from end-market demand for its products. Also, innovative products and expansionary efforts will prove advantageous.
Olin Corporation (OLN) Soars: Stock Adds 6.6% in Session
by Zacks Equity Research
Olin Corporation (OLN) saw its shares rise nearly 7% on the day.
AK Steel (AKS) Reaches New Labor Deal at Rockport Works
by Zacks Equity Research
AK Steel (AKS) and United Auto Workers Local 3044 have entered into a four-year labor agreement which covers 319 hourly production employees at the company's Rockport Works, Indiana.
Celanese (CE) Set to Increase Prices of Emulsion Polymers
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
3 Reasons to Add FMC Corp. (FMC) Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe FMC Corp. (FMC) has plenty of upside potential.
FMC Corp Gets CCI Approval for Crop Protection Assets Buy
by Zacks Equity Research
The proposed acquisition of a major portion of DuPont's Crop Protection business has provided a significant growth platform for FMC Corp.'s (FMC) agricultural business.
FMC Corp (FMC) Up 22% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
Strong second-quarter results and upbeat prospects for the Lithium unit have provided a boost to FMC Corp.'s (FMC) shares.
FMC Corp Poised on Lithium Unit Strength, Growth Actions
by Zacks Equity Research
Strength in the Lithium division and upbeat prospects in the agriculture business will benefit FMC Corp. (FMC).
FMC Up 11.5% Since Earnings Report: Can It Continue?
by Zacks Equity Research
FMC reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
FMC Corp (FMC) Touches New 52-Week High: What's Driving It?
by Zacks Equity Research
Strength in the Lithium unit and upbeat prospects stemming from the planned acquisition of DuPont's assets are driving FMC Corp. (FMC).
FMC Corporation (FMC) Jumps: Stock Rises 8.4%
by Zacks Equity Research
FMC Corporation (FMC) was a big mover last session, as the company saw its shares rise over 8% on the day amid huge volumes.
FMC Corp's (FMC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Strong performance at the Lithium unit contributed to FMC Corp's (FMC) Q2 results.
Chemical Stocks' Earnings to Watch on Aug 1: APD, FMC
by Zacks Equity Research
The chemical industry's momentum is expected to continue in Q2 on continued strength across major end-use markets.
FMC Corp (FMC) Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
Weakness in agriculture may weigh on FMC Corp.'s (FMC) second-quarter results.
Zacks Industry Outlook Highlights: FMC, PPG Industries, Huntsman, Methanex and H.B. Fuller
by Zacks Equity Research
Zacks Industry Outlook Highlights: FMC, PPG Industries, Huntsman, Methanex and H.B. Fuller
6 Reasons to Add Koppers (KOP) Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe Koppers (KOP) has plenty of upside potential.
PolyOne Buys Mesa, Expands Color & Additives Offerings
by Zacks Equity Research
PolyOne (POL) has purchased Mesa, a North American producer of color and additive materials and services.
FMC Corp (FMC) to Sell Epax Omega-3 Business to Pelagia
by Zacks Equity Research
FMC Corp. (FMC) has agreed to divest its Epax Omega-3 business to Pelagia AS for an undisclosed price.
DuPont (DD) & FMC Corp Asset Deal Gets U.S. Antitrust Approval
by Zacks Equity Research
DuPont (DD) announced that the waiting periods for the approval of its transactions with FMC Corporation (FMC) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 have expired on Jun 9.
FMC Corp (FMC) Up 5.7% Since Earnings Report: Can It Continue?
by Zacks Equity Research
FMC Corp (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.